Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema ...
While popular drugs like Ozempic and Wegovy are only available as injections, drugmaker Novo Nordisk is working on a more convenient option: A pill. Novo Nordisk already makes semaglutide ...
LONDON/SAN FRANCISCO (Reuters) - Novo Nordisk is under pressure from investors ... be more powerful than its blockbuster weight-loss injection Wegovy, but investors are worried whether it will ...